Relating to the Review of Additional Items. For each Additional Item reviewed: a. a description of the review conducted; b. the IRO’s findings based on its review; c. the findings and supporting rationale regarding any weaknesses in RMS’s systems, processes, policies, procedures, and practices relating to the Additional Item, if any; and d. recommendations, if any, for changes in RMS’s systems, processes, policies, and procedures that would correct or address any weaknesses or deficiencies uncovered during the review.
Appears in 1 contract
Sources: Corporate Integrity Agreement (Ra Medical Systems, Inc.)
Relating to the Review of Additional Items. For each Additional Item reviewed:reviewed:
a. a A description of the review conducted;conducted;
b. the The IRO’s findings based on its review;review;
c. the The findings and supporting rationale regarding any weaknesses in RMSACell’s systems, processes, policies, procedures, and practices relating to the Additional Item, if any; andand
d. recommendationsRecommendations, if any, for changes in RMSACell’s systems, processes, policies, and procedures that would correct or address any weaknesses or deficiencies uncovered during the review.the
Appears in 1 contract
Sources: Corporate Integrity Agreement
Relating to the Review of Additional Items. For each Additional Item reviewed:reviewed:
a. a description of the review conducted;conducted;
b. the IRO’s findings based on its review;review;
c. the findings and supporting rationale regarding any weaknesses in RMS’s systems, processes, policies, procedures, and practices relating to the Additional Item, if any; and
d. recommendations, if any, for changes in RMS’s systems, processes, policies, and procedures that would correct or address any weaknesses or deficiencies uncovered during the review.and
Appears in 1 contract
Sources: Corporate Integrity Agreement